We have found 46588 results matching your criteria.
Please wait while we search...
  1. 1.
    General Material Information
  2. 2.
    PhysChem Properties
  3. 3.
    Occurrences
  4. 4.
    Organoleptic Properties
  5. 5.
    Suppliers
  6. 6.
    Potential Uses
  7. 7.
    Regulatory & Documentation
  8. 8.
    Safety Information
  9. 9.
    Other Information
  10. 10.
    Blenders & Components
  11. 11.
    Literature & References

laevo-cysteine hydrochloride anhydrous

Chemical Structure

General Material Information

Preferred name laevo-cysteine hydrochloride anhydrous
Trivial Name L-(+)-Cysteine hydrochloride
Short Description L-cystein hydrochloride
Formula C3 H8 N O2 S Cl
CAS Number 52-89-1
Deleted CAS Number 122641-75-2
Flavis Number 17.032
ECHA Number 200-157-7
FDA UNII A9U1687S1S
Beilstein Number 3560277
MDL MFCD00064553
COE Number 11746
Bio Activity Summary External link
NMR Predictor External link
FDA Mainterm 52-89-1 ; L-CYSTEINE MONOHYDROCHLORIDE
Synonyms
  • (R)-2-amino-3-mercaptopropanoic acid hydrochloride
  • L-2-amino-3-mercaptopropanoic acid monohydrochloride
  • (2R)-2-amino-3-sulfanylpropanoic acid hydrochloride
  • L- cystein hydrochloride
  • L- cysteine HCl Anhydrous
  • (R)- cysteine hydrochloride
  • (R)-(+)- cysteine hydrochloride
  • L- cysteine hydrochloride
  • L-(+)- cysteine hydrochloride
  • L- cysteine hydrochloride (1:1)
  • (R)- cysteine hydrochloride anhydrous
  • L- cysteine hydrochloride anhydrous
  • laevo-(+)- cysteine hydrochloride anhydrous
  • L- cysteine monohydrochloride anhydrous
  • laevo- cysteine monohydrochloride anhydrous
  • cysteine, hydrochloride, L-
  • cysteine, L-, hydrochloride
  • cysteine, L-, monohydrochloride
  • L- cysteine.HCl
  • L- cysteinehydrochloride
  • L-Cysteine, hydrochloride (1:1)
  • L-Cysteine, hydrochloride
  • Cysteine chlorohydrate
  • Cysteine hydrochloride
  • Cystein chloride
  • L-(+)-Cysteine hydrochloride
  • (R)-Cysteine hydrochloride
  • WR 348
  • (R)-1-Carboxy-2-mercaptoethanaminium chloride
  • CSKE 200
  • (2R)-2-Amino-3-sulfanylpropanoic acid hydrochloride

US / EU / FDA / JECFA / FEMA / Scholar / Patents

Google Scholar Start search
Google Books Start search
Google Patents Start search
Perfumer & Flavorists Start search
EU Patents Start search
PubMeb Start search
NCBI Start search

Literature & References

(2R)-2-amino-3-sulfanylpropanoic acid hydrochloride
NIST Chemistry WebBook:Search Inchi
Canada Domestic Sub. List:52-89-1
Pubchem (cid):60960
Pubchem (sid):135017561
Publications by PubMed
Synthesis of highly luminescent and biocompatible CdTe/CdS/ZnS quantum dots using microwave irradiation: a comparative study of different ligands.
Impaired L-arginine uptake but not arginase contributes to endothelial dysfunction in rats with chronic kidney disease.
Culture media for differential isolation of Lactobacillus casei Shirota from oral samples.
Arginase II inhibition prevents nitrate tolerance.
Extracellular signal-regulated kinase (ERK) inhibition decreases arginase activity and improves corpora cavernosal relaxation in streptozotocin (STZ)-induced diabetic mice.
Hypoxia-reduced nitric oxide synthase activity is partially explained by higher arginase-2 activity and cellular redistribution in human umbilical vein endothelium.
Intrinsic susceptibility of Giardia duodenalis assemblage subtypes A(I), A(II), B and E(III) for nitric oxide under axenic culture conditions.
Buccal tablets containing cysteine and chlorhexidine for the reduction of acetaldehyde levels in the oral cavity.
Design, synthesis and biological activity of thiazolidine-4-carboxylic acid derivatives as novel influenza neuraminidase inhibitors.
Screening of reducing agents for anaerobic growth of Candida albicans SC5314.
The effect of the combination of reducing and oxidising agents on the viscoelastic properties of dough and sensory characteristics of buns.
On-line pre-reduction of pentavalent arsenicals by thioglycolic acid for speciation analysis by selective hydride generation-cryotrapping-atomic absorption spectrometry.
Multifunctional multilayer films containing polyoxometalates and bismuth oxide nanoparticles.
Optimization of a reconstituted skim milk based medium for enhanced CLA production by bifidobacteria.
The vascular effects of different arginase inhibitors in rat isolated aorta and mesenteric arteries.
Disappearance of nine monoterpenes exposed in vitro to the rumen microflora of dairy goats: effects of inoculum source, redox potential, and vancomycin.
Arginase blockade lessens endothelial dysfunction after thrombosis.
Optoelectronic characteristics of inorganic/organic hybrid device based on poly(N-vinylcarbazole)/ cadmium selenide thin films.
Synthesis and optical properties of L-cysteine hydrochloride-stabilized CdSe nanocrystals in a new alkali system.
Comparison of methods with respect to efficiencies, recoveries, and quantitation of mercury species interconversions in food demonstrated using tuna fish.
Formulation and in-vivo evaluation of L-cysteine chewing gums for binding carcinogenic acetaldehyde in the saliva during smoking.
Optimization of acetic acid production from synthesis gas by chemolithotrophic bacterium--Clostridium aceticum using statistical approach.
Local ascorbate administration augments NO- and non-NO-dependent reflex cutaneous vasodilation in hypertensive humans.
Expression of the mucus adhesion genes Mub and MapA, adhesion-like factor EF-Tu and bacteriocin gene plaA of Lactobacillus plantarum 423, monitored with real-time PCR.
Study on organic nitrates, part VIII. Pharmacological activity and nitric oxide generation capacity of nitrate derivatives of piperazine.
Self-assembly of L-cysteine-copper(II)/copper(I) multilayer thin films on gold.
Activity of faropenem tested against Neisseria gonorrhoeae isolates including fluoroquinolone-resistant strains.
Properties of a thermostable extracellular lipase from Bacillus megaterium AKG-1.
Differential electrolytic potentiometric determination of some thiol compounds in their dosage forms.
Effect of antioxidants added to boar semen extender on the semen survival time and sperm chromatin structure.
Long-term treatment of erythropoietic protoporphyria with cysteine.
Factors influencing bacterial attachment to the ruminal epithelium in vitro.
Optimum production, stability, partial purification and inhibitory spectrum of antimicrobial compounds produced by Pediococcus pentosaceus DI.
Efficient translocation and processing with Xenopus egg extracts of proteins synthesized in rabbit reticulocyte lysate.
Chromium and zinc contamination of parenteral nutrient solution components commonly used in infants and children.
Abiotrophia elegans sp. nov., a possible pathogen in patients with culture-negative endocarditis.
Reducing medium for the cultivation of Porphyromonas gingivalis.
Growth of the fish pathogen Renibacterium salmoninarum on different media.
Somatic embryogenesis from integument (perisperm) cultures of coffee.
Chemotactic response to mucin by Serpulina hyodysenteriae and other porcine spirochetes: potential role in intestinal colonization.
Prefilter and postfilter cysteine/cystine and copper concentrations in pediatric parenteral nutrition solutions.
An antibiotic-free medium for the xenic cultivation of Entamoeba gingivalis.
[Ecosystem of microbial flora in periodontal pockets, in vitro].
Growth studies on xenic cultures of Entamoeba gingivalis using established media.
An ESR study of radical kinetics in L-alpha-amino-n-butyric acid hydrochloride containing L-cysteine hydrochloride.
An ESR study of the radicals in X-irradiated L-alpha-amino-n-butyric acid HCl containing 1.5% L-cysteine HCl.
[Role of sodium pyrosulfite and L-cysteine hydrochloride in retarding discoloration of ascorbic acid injection].
Charcoal agar, a new growth medium for the fish disease bacterium Renibacterium salmoninarum.
[Methods of determination of L-cysteine hydrochloride and sodium pyrosulfite in 25% ascorbic acid injection].
Antimycotic activity of some amino acids against dermatophytes.
Factors promoting in vitro excystation of Giardia muris cysts.
Egg-yolk trypticase soy agar for the enumeration of heat-damaged spores of Clostridium sporogenes.
Effect of intermittent and continuous administration of L-cysteine hydrochloride on L1210 mouse leukemia.
A simple disc technique for the presumptive identification of Legionella pneumophila.
Tolerance of the chick to excess dietary cadmium as influenced by dietary cysteine and by experimental infection with Eimeria acervulina.
Cell detachment and cloning efficiency as parameters for cytotoxicity.
Carbohydrate fermentation by Clostridium difficile.
Quantitative procedure for enumeration of bifidobacteria.
The effect of methionine or cysteine on cobalt toxicity in the chick.
Effects of adding potassium iodate to milk before UHT treatment. I. Reduction in the amount of deposit on the heated surfaces.
[Solubility of metallic mercury into the solutions containing various amino acids (author's transl)].
Primary isolation media for Legionnaires disease bacterium.
A study of the rates of the competitive nitrosations of pyrrolidine, p-cresol and L-cysteine hydrochloride.
Sulfite oxidase deficiency. Biochemical and clinical investigations of a hereditary metabolic disorder in sulfur metabolism.
The action of cysteine of PHA-stimulation of lymphocytes. II. Influence on incorporation of 3H-uridine and 14C-leucine.
Corynebacterial kidney disease of salmonids: growth and serological studies on the causative bacterium.
Suppression of MLC-reactivity of rat lymphocytes by L-cysteine hydrochloride.
Heat resistance of spores of marine and terrestrial strains of Clostridium botulinum type C.
Enrichment, isolation, and cultural characteristics of marine strains of Clostridium botulinum type C.
Possible explanation for the metabolic radioprotective effect of cysteine on Escherichia coli B.
[A new percentage assay for L-cysteine, L-cysteine HCl D-penicillamine, D-penicillamine HCl and N-acetyl-D-penicillamine. A critical evaluation method of a number of assay methods].
Amino Acid and vitamin requirements of several bacteroides strains.
Effect of sodium chloride and pH on the outgrowth of spores of type E Clostridium botulinum at optimal and suboptimal temperatures.
PARAMAGNETIC RESONANCE IN L-CYSTEINE HYDROCHLORIDE IRRADIATED AT 77K.
The use of L-cysteine hydrochloride to protect against the lethal effects of various alkylating agents.
A transparent solid medium for growth enhancement of Pasteurella tularensis.
Effect of L-cysteine hydrochloride, DL-alanine, hydrochloric acid and sodium hydrosulfide on experimental polyarthritis of rats.

Other Information

(IUPAC):Atomic Weights of the Elements 2011 (pdf)
Videos:The Periodic Table of Videos
tgsc:Atomic Weights use for this web site
(IUPAC):Periodic Table of the Elements
FDA Substances Added to Food (formerly EAFUS):View
CHEBI:View
CHEMBL:View
HMDB (The Human Metabolome Database):Search
FooDB:FDB012679
FDA Listing of Food Additive Status:View
ChemSpider:View

PhysChem Properties

Material listed in food chemical codex No
Molecular weight 157.61915588379
Boiling Point 290 to 293°C @ 760 mm Hg
Vapor Pressure 0.000411 mmHg @ 25 °C
Flash Point TCC Value 131.11 °C TCC
logP (o/w) 0.235 est
Solubility
water, 1.132e+005 mg/L @ 25 °C (est) Yes

Safety Information

Safety information

Preferred SDS: View
European information :
Most important hazard(s):
Xi - Irritant
R 36/37/38 - Irritating to eyes, respiratory system, and skin.
S 02 - Keep out of the reach of children.
S 24/25 - Avoid contact with skin and eyes.
S 26 - In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.
S 36 - Wear suitable protective clothing.
Hazards identification
Classification of the substance or mixture
GHS Classification in accordance with 29 CFR 1910 (OSHA HCS)
None found.
GHS Label elements, including precautionary statements
Pictogram
Hazard statement(s)
None found.
Precautionary statement(s)
None found.
Oral/Parenteral Toxicity:
intraperitoneal-mouse LD50 1250 mg/kg
National Technical Information Service. Vol. AD691-490

intravenous-mouse LD50 771 mg/kg
Japanese Journal of Antibiotics. Vol. 38, Pg. 137, 1985.

unreported-mouse LD50 3000 mg/kg
British Journal of Cancer. Vol. 6, Pg. 160, 1952.

Dermal Toxicity:
Not determined
Inhalation Toxicity:
Not determined

Safety in use information

Category:
special dietary and nutritional additives
Recommendation for laevo-cysteine hydrochloride anhydrous usage levels up to:
not for fragrance use.
Recommendation for laevo-cysteine hydrochloride anhydrous flavor usage levels up to:
not for flavor use.

Safety references

European Food Safety Authority (EFSA) reference(s):

Amino acids from chemical group 34 Flavouring Group Evaluation 26, Revision 1 - Scientific opinion of the Panel on Food Additives, Flavourings, Processing Aids and Materials in contact with Food (AFC)
View page or View pdf

Flavouring Group Evaluation 29 (FGE29)[1] - Substance from the priority list: Vinylbenzene from chemical group 31 - Scientific Opinion of the Panel on Food Additives, Flavourings, Processing Aids and Materials in Contact with Food (AFC)
View page or View pdf

Flavouring Group Evaluation 79, (FGE.79)[1] - Consideration of amino acids and related substances evaluated by JECFA (63rd meeting) structurally related to amino acids from chemical group 34 evaluated by EFSA in FGE.26Rev1 (2008)
View page or View pdf

Scientific Opinion on Flavouring Group Evaluation 49, Revision 1 (FGE.49Rev1): xanthine alkaloids from the priority list
View page or View pdf

EPI System: View
ClinicalTrials.gov:search
Daily Med:search
Chemical Carcinogenesis Research Information System:Search
AIDS Citations:Search
Cancer Citations:Search
Toxicology Citations:Search
Carcinogenic Potency Database:Search
EPA Substance Registry Services (TSCA):52-89-1
EPA ACToR:Toxicology Data
EPA Substance Registry Services (SRS):Registry
Laboratory Chemical Safety Summary :60960
National Institute of Allergy and Infectious Diseases:Data
WGK Germany:3
(2R)-2-amino-3-sulfanylpropanoic acid hydrochloride
Chemidplus:0000052891
RTECS:HA2275000 for cas# 52-89-1